| 000 | 01871 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517010857.0 | ||
| 264 | 0 | _c20150611 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1533-3450 | ||
| 024 | 7 |
_a10.1681/ASN.2013101137 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXavier, Sandhya | |
| 245 | 0 | 0 |
_aCurtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD. _h[electronic resource] |
| 260 |
_bJournal of the American Society of Nephrology : JASN _cApr 2015 |
||
| 300 |
_a817-29 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Transdifferentiation |
| 650 | 0 | 4 | _aEndoglin |
| 650 | 0 | 4 |
_aEndothelium _xmetabolism |
| 650 | 0 | 4 | _aFibrosis |
| 650 | 0 | 4 | _aFolic Acid |
| 650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xmetabolism |
| 650 | 0 | 4 |
_aKidney _xpathology |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 | _aNeovascularization, Physiologic |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xgenetics |
| 650 | 0 | 4 | _aReceptor, Transforming Growth Factor-beta Type II |
| 650 | 0 | 4 |
_aReceptors, Transforming Growth Factor beta _xgenetics |
| 650 | 0 | 4 |
_aRenal Insufficiency, Chronic _xmetabolism |
| 650 | 0 | 4 |
_aSmad Proteins _xmetabolism |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xmetabolism |
| 650 | 0 | 4 | _aUreteral Obstruction |
| 700 | 1 | _aVasko, Radovan | |
| 700 | 1 | _aMatsumoto, Kei | |
| 700 | 1 | _aZullo, Joseph A | |
| 700 | 1 | _aChen, Robert | |
| 700 | 1 | _aMaizel, Julien | |
| 700 | 1 | _aChander, Praveen N | |
| 700 | 1 | _aGoligorsky, Michael S | |
| 773 | 0 |
_tJournal of the American Society of Nephrology : JASN _gvol. 26 _gno. 4 _gp. 817-29 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1681/ASN.2013101137 _zAvailable from publisher's website |
| 999 |
_c24483302 _d24483302 |
||